Cargando…

Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK

Detalles Bibliográficos
Autores principales: Bromley, Susan E., Matthews, Anthony, Smeeth, Liam, Stanway, Susannah, Bhaskaran, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881411/
https://www.ncbi.nlm.nih.gov/pubmed/31641936
http://dx.doi.org/10.1007/s11764-019-00806-5
_version_ 1783473943254925312
author Bromley, Susan E.
Matthews, Anthony
Smeeth, Liam
Stanway, Susannah
Bhaskaran, Krishnan
author_facet Bromley, Susan E.
Matthews, Anthony
Smeeth, Liam
Stanway, Susannah
Bhaskaran, Krishnan
author_sort Bromley, Susan E.
collection PubMed
description
format Online
Article
Text
id pubmed-6881411
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-68814112019-12-12 Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK Bromley, Susan E. Matthews, Anthony Smeeth, Liam Stanway, Susannah Bhaskaran, Krishnan J Cancer Surviv Correction Springer US 2019-10-22 2019 /pmc/articles/PMC6881411/ /pubmed/31641936 http://dx.doi.org/10.1007/s11764-019-00806-5 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Bromley, Susan E.
Matthews, Anthony
Smeeth, Liam
Stanway, Susannah
Bhaskaran, Krishnan
Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
title Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
title_full Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
title_fullStr Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
title_full_unstemmed Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
title_short Correction to: Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK
title_sort correction to: risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the uk
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881411/
https://www.ncbi.nlm.nih.gov/pubmed/31641936
http://dx.doi.org/10.1007/s11764-019-00806-5
work_keys_str_mv AT bromleysusane correctiontoriskofdementiaamongpostmenopausalbreastcancersurvivorstreatedwitharomataseinhibitorsversustamoxifenacohortstudyusingprimarycaredatafromtheuk
AT matthewsanthony correctiontoriskofdementiaamongpostmenopausalbreastcancersurvivorstreatedwitharomataseinhibitorsversustamoxifenacohortstudyusingprimarycaredatafromtheuk
AT smeethliam correctiontoriskofdementiaamongpostmenopausalbreastcancersurvivorstreatedwitharomataseinhibitorsversustamoxifenacohortstudyusingprimarycaredatafromtheuk
AT stanwaysusannah correctiontoriskofdementiaamongpostmenopausalbreastcancersurvivorstreatedwitharomataseinhibitorsversustamoxifenacohortstudyusingprimarycaredatafromtheuk
AT bhaskarankrishnan correctiontoriskofdementiaamongpostmenopausalbreastcancersurvivorstreatedwitharomataseinhibitorsversustamoxifenacohortstudyusingprimarycaredatafromtheuk